View by Specialty

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

Alzheimer’s Disease/Dementia News

SPONSORED CONTENT
Save
SPONSORED CONTENT
September 25, 2023
1 min read
Save

FDA grants 510(k) clearance for Alzheimer’s, dementia diagnosis software

FDA grants 510(k) clearance for Alzheimer’s, dementia diagnosis software

The FDA has granted 510(k) clearance to German medical technology company AIRAmed for its medical image management and processing system designed to assist physicians in early detection of Alzheimer’s disease and other dementias.

SPONSORED CONTENT
September 15, 2023
2 min read
Save

Diagnosis, treatment, clinical trials obstacles to addressing dementia with Lewy bodies

Diagnosis, treatment, clinical trials obstacles to addressing dementia with Lewy bodies

PHILADELPHIA — To effectively address symptoms of dementia with Lewy bodies, the medical community must address obstacles such as accurate diagnosis, lack of treatment options and dearth of clinical trials, according to a presenter.

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

SPONSORED CONTENT
September 09, 2023
2 min read
Save

DOACs reduce risk for dementia in AF vs. warfarin, especially in Asian patients

DOACs reduce risk for dementia in AF vs. warfarin, especially in Asian patients

Compared with warfarin, direct oral anticoagulants were associated with reduced risk for dementia in patients with atrial fibrillation, particularly those from Asian populations, according to a systematic review and meta-analysis.

SPONSORED CONTENT
September 08, 2023
2 min read
Save

Infections more likely indicator of dementia than autoimmune disease

Infections more likely indicator of dementia than autoimmune disease

Infection-specific processes, rather than general systemic inflammation, may play a role in the development of dementia among those with hospital-diagnosed infections, according to research from JAMA Network Open.

SPONSORED CONTENT
September 06, 2023
2 min read
Save

Dementia diagnosis is ‘underused opportunity’ to reduce polypharmacy

Dementia diagnosis is ‘underused opportunity’ to reduce polypharmacy

Patients with post-incident dementia were more likely to begin central nervous system medications and less likely to discontinue cardiometabolic and anticholinergic medications, reflecting missed deprescribing opportunities, according to researchers.

SPONSORED CONTENT
September 01, 2023
5 min read
Save

Q&A: The 'insidious, chronic effects' of long-term heat exposure

Q&A: The 'insidious, chronic effects' of long-term heat exposure

Long-term exposure to extreme heat can lead to cognitive decline, according to experts.

SPONSORED CONTENT
August 30, 2023
3 min read
Save

Q&A: AI identifies key social determinants of health for patients with dementia

Q&A: AI identifies key social determinants of health for patients with dementia

Artificial intelligence could help clinicians address the social needs of patients with dementia, according to Elham Mahmoudi, PhD.

SPONSORED CONTENT
August 21, 2023
3 min read
Save

Air pollution associated with higher rates of dementia, poor health

Air pollution associated with higher rates of dementia, poor health

Greater residential levels of fine particulate matter air pollution, especially from agriculture and wildfires, were linked to higher rates of dementia, according to study results published in JAMA Internal Medicine.

SPONSORED CONTENT
August 18, 2023
1 min read
Save

Blood test boosts diagnostic accuracy for Alzheimer’s by calculating amyloid probability

Blood test boosts diagnostic accuracy for Alzheimer’s by calculating amyloid probability

C2N Diagnostics released the PrecivityAD2 blood test, which uses positron emission tomography scans and cerebrospinal fluid tests to assist in accurate diagnosis for those presenting with signs or symptoms of Alzheimer’s disease.

SPONSORED CONTENT
August 11, 2023
1 min read
Save

Anti-amyloid drug shows significant immune response in adults with mild Alzheimer’s

Anti-amyloid drug shows significant immune response in adults with mild Alzheimer’s

Treatment with an investigational anti-amyloid therapeutic for adults with mild Alzheimer’s disease was safe, efficacious and demonstrated a significant immune response up to 78 weeks, per a study published in EBioMedicine.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails